Research ArticleArticle
Baseline Glucocorticoid Dose and Bone Mineral Density Response with Teriparatide or Alendronate Therapy in Patients with Glucocorticoid-induced Osteoporosis
JEAN-PIERRE DEVOGELAER, ROBERT A. ADLER, CHRIS RECKNOR, KYOUNGAH SEE, MARGARET R. WARNER, MAYME WONG and KELLY KROHN
The Journal of Rheumatology January 2010, 37 (1) 141-148; DOI: https://doi.org/10.3899/jrheum.090411
JEAN-PIERRE DEVOGELAER
ROBERT A. ADLER
CHRIS RECKNOR
KYOUNGAH SEE
MARGARET R. WARNER
MAYME WONG
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- Marcus R,
- Feldman D,
- Nelson DA,
- Rosen CJ
- Adler RA,
- Curtis J,
- Weinstein RS,
- Saag KG
- 4.↵
- 5.↵
- 6.↵
- 7.↵
- 8.↵
- Hoes JN,
- Jacobs JW,
- Boers M,
- Boumpas D,
- Buttgereit F,
- Caeyers N,
- et al.
- 9.↵
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- Lane NE,
- Sanchez S,
- Modin GW,
- Genant HK,
- Pierini E,
- Arnaud CD
- 14.↵
- 15.↵Forteo™ product label. [Internet. Accessed Oct 27, 2009.] Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021318s015lbl.pdf
- 16.↵Fosamax® product label. [Internet. Accessed October 7, 2009.] Available from: http://www.merck.com/product/usa/pi_circulars/f/fosamax/fosamax_oncedaily_ppi.pdf
- 17.↵
- 18.↵
- Adachi JD,
- Saag KG,
- Delmas PD,
- Liberman UA,
- Emkey RD,
- Seeman E,
- et al.
- 19.↵
- 20.↵
- 21.↵
- 22.↵
- 23.↵
- Emkey R,
- Delmas PD,
- Goemaere S,
- Liberman UA,
- Poubelle PE,
- Daifotis AG,
- et al.
- 24.↵
- Lane NE,
- Yao W,
- Balooch M,
- Nalla RK,
- Balooch G,
- Habelitz S,
- et al.
- 25.↵
- Sosa M,
- Jódar E,
- Saavedra P,
- Navarro MC,
- Gómez de Tejada MJ,
- Martín A,
- et al.
- 26.↵
- 27.↵
- 28.↵
- 29.↵
In this issue
The Journal of Rheumatology
Vol. 37, Issue 1
1 Jan 2010
Baseline Glucocorticoid Dose and Bone Mineral Density Response with Teriparatide or Alendronate Therapy in Patients with Glucocorticoid-induced Osteoporosis
JEAN-PIERRE DEVOGELAER, ROBERT A. ADLER, CHRIS RECKNOR, KYOUNGAH SEE, MARGARET R. WARNER, MAYME WONG, KELLY KROHN
The Journal of Rheumatology Jan 2010, 37 (1) 141-148; DOI: 10.3899/jrheum.090411
Baseline Glucocorticoid Dose and Bone Mineral Density Response with Teriparatide or Alendronate Therapy in Patients with Glucocorticoid-induced Osteoporosis
JEAN-PIERRE DEVOGELAER, ROBERT A. ADLER, CHRIS RECKNOR, KYOUNGAH SEE, MARGARET R. WARNER, MAYME WONG, KELLY KROHN
The Journal of Rheumatology Jan 2010, 37 (1) 141-148; DOI: 10.3899/jrheum.090411